Bone Biologics Corp Files 8-K on Security Holder Vote
Ticker: BBLGW · Form: 8-K · Filed: Sep 19, 2024 · CIK: 1419554
| Field | Detail |
|---|---|
| Company | Bone Biologics Corp (BBLGW) |
| Form Type | 8-K |
| Filed Date | Sep 19, 2024 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-governance, filing-update
Related Tickers: BBLG
TL;DR
BBLG filed an 8-K on Sept 17th regarding a security holder vote. Check for shareholder impact.
AI Summary
Bone Biologics Corporation filed an 8-K on September 19, 2024, reporting on matters submitted to a vote of security holders on September 17, 2024. The filing details the company's corporate structure, including its incorporation in Delaware and its fiscal year end of December 31. Bone Biologics Corporation operates in the orthopedic, prosthetic & surgical appliances & supplies industry.
Why It Matters
This filing provides an update on corporate governance matters, specifically a vote by security holders, which can impact shareholder rights and company direction.
Risk Assessment
Risk Level: low — This filing is a routine corporate disclosure regarding a security holder vote and does not appear to contain significant new financial or operational risks.
Key Players & Entities
- Bone Biologics Corporation (company) — Registrant
- September 17, 2024 (date) — Date of earliest event reported
- September 19, 2024 (date) — Date of report
- Delaware (jurisdiction) — State of incorporation
FAQ
What specific matters were submitted to a vote of security holders on September 17, 2024?
The filing indicates that matters were submitted to a vote of security holders on September 17, 2024, but the specific details of these matters are not provided in the provided text.
What is Bone Biologics Corporation's primary industry?
Bone Biologics Corporation is in the ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES industry, with SIC code 3842.
When is Bone Biologics Corporation's fiscal year end?
Bone Biologics Corporation's fiscal year ends on December 31.
What is the SEC file number for Bone Biologics Corporation?
The SEC file number for Bone Biologics Corporation is 001-40899.
Where is Bone Biologics Corporation headquartered?
Bone Biologics Corporation's business address is 2 BURLINGTON WOODS DRIVE, SUITE 100, BURLINGTON, MA 01803.
Filing Stats: 565 words · 2 min read · ~2 pages · Grade level 12 · Accepted 2024-09-19 17:00:09
Key Financial Figures
- $0.001 — ch registered Common Stock, par value $0.001 per share BBLG Nasdaq Capital Mark
Filing Documents
- form8-k.htm (8-K) — 54KB
- 0001493152-24-037146.txt ( ) — 267KB
- bblg-20240917.xsd (EX-101.SCH) — 4KB
- bblg-20240917_def.xml (EX-101.DEF) — 26KB
- bblg-20240917_lab.xml (EX-101.LAB) — 36KB
- bblg-20240917_pre.xml (EX-101.PRE) — 25KB
- form8-k_htm.xml (XML) — 6KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. BONE BIOLOGICS CORPORATION Date: September 19, 2024 By: /s/ JEFFREY FRELICK Jeffrey Frelick, Chief Executive Officer